☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Covid-19 pneumonia
Pfizer Presents Results of Tofacitinib in STOP-COVID Study for Patients Hospitalized with COVID-19 Pneumonia at NEJM
June 17, 2021
Roche's Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Sev...
March 11, 2021
Novartis' Ilaris (canakinumab) Fails to Meet its Primary Endpoints in P-lll Study for COVID-19 Pneumonia and CRS
November 9, 2020
Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia
April 29, 2020
Roche to Initiate P-III COVACTA Study of Actemra/RoActemra in Hospitalized Patients with Severe Covid-19 Pneumonia in Collaboratio...
March 19, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.